Over the years, we have collected millions of dollars for our clients
Tesamorelin specifically targets visceral fat (the deep belly fat surrounding your organs) by stimulating natural growth hormone release, reducing this dangerous fat by 15-18% in clinical trials
A dip in eGFR is evidence of a reduction in high pressure in the small blood vessels that filter the blood in the kidney
Our research team tracks every FDA signal, reimbursement change, and clinical trial update to keep your positions ahead of market consensus
Woman shares journey of weight loss and gain after using semaglutide One woman shares how she lost 50 pounds using the popular medication to aid weight loss, including side effects and what happened when she stopped taking the medication
Gastrointestinal discomfort, including bloating and diarrhoea, can occur, particularly with higher doses